Phathom Pharmaceuticals Upgraded to Buy Heres What You Should Know
| PHAT Stock | USD 5.99 0.35 5.52% |
Slightly above 62% of Phathom Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Phathom Pharmaceuticals stock suggests that many investors are alarmed at this time. Phathom Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Phathom Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Phathom |
Phathom Pharmaceuticals has been upgraded to a Zacks Rank 2 , reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Read at zacks.com
 |
Phathom Pharmaceuticals Fundamental Analysis
We analyze Phathom Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phathom Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phathom Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Phathom Pharmaceuticals is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Phathom Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Phathom Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Phathom Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Phathom Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Phathom Pharmaceuticals Related Equities
| XFOR | X4 Pharmaceuticals | 6.06 | ||||
| AMLX | Amylyx Pharmaceuticals | 3.99 | ||||
| GPCR | Structure Therapeutics | 1.15 | ||||
| BPMC | Blueprint Medicines | 1.33 | ||||
| INZY | Inozyme Pharma | 1.37 | ||||
| IMMX | Immix Biopharma | 1.52 | ||||
| KNSA | Kiniksa Pharmaceuticals | 3.78 | ||||
| DAWN | Day One | 3.81 | ||||
| CGEM | Cullinan Oncology | 3.83 | ||||
| ABOS | Acumen Pharmaceuticals | 3.85 | ||||
| TERN | Terns Pharmaceuticals | 3.88 | ||||
| LYRA | Lyra Therapeutics | 5.26 | ||||
| HEPA | Hepion Pharmaceuticals | 5.26 |
Additional Tools for Phathom Stock Analysis
When running Phathom Pharmaceuticals' price analysis, check to measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.